Evaluating the efficacy and safety of calcipotriene/betamethasone ointment occluded with a hydrogel patch: A 6-week bilaterally controlled, investigator-blinded trial

Cutis

Volumn 88, Issue 3, 2011, Pages 149-154

  Patel, Tejas ^a   Bhutani, Tina ^b   Busse, Kristine L ^c   Koo, John ^b,d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WRIGHT STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BETAMETHASONE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE-17,21-DIPROPIONATE; CALCIPOTRIOL; CALCITRIOL; DERMATOLOGICAL AGENT; DRUG DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYDROGEL; MALE; MIDDLE AGED; OCCLUSIVE DRESSING; OINTMENT; PATHOLOGY; PSORIASIS; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; CALCITRIOL; DERMATOLOGIC AGENTS; FEMALE; HUMANS; HYDROGEL; MALE; MIDDLE AGED; OCCLUSIVE DRESSINGS; OINTMENTS; PSORIASIS; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 82355160624     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. About psoriasis: statistics. National Psoriasis Foundation Web site. http://www.psoriasis.org/about-psoriasis/statistics. Accessed August 18, 2011.
2. Shore RN. Clearing of psoriatic lesions after the application of tape. N Engl J Med. 1985;312:246.
3. Shore RN. Treatment of psoriasis with prolonged application of tape. J Am Acad Dermatol. 1986;15:540-542.
4. Colaco SM, Fitzmaurice S, Becker E, et al. New developments in topical psoriasis therapy. In: Koo JYM, Lee CS, Lebwohl MG, eds. Mild to Moderate Psoriasis. New York, NY: Informa Healthcare; 2009:165-181.
5. Hwang SM, Ahn SK, Menon GK, et al. Basis of occlusive therapy in psoriasis: correcting defects in permeability barrier and calcium gradient. Int J Dermatol. 2001;40:223-231.
6. Fry L, Almeyda J, McMinn RM. Effect of plastic occlusive dressings on psoriatic epidermis. Br J Dermatol. 1970;82:458-462.
7. Fisher LB, Maibach HI. Physical occlusion controlling epidermal mitosis. J Invest Dermatol. 1972;59:106-108.
8. Rovee DT, Kurowsky CA, Labun J. Local wound environment and epidermal healing. mitotic response. Arch Dermatol. 1972;106:330-334.
9. Van Scott EJ, Yu RJ. Hyperkeratinization, corneocyte cohesion, and alpha hydroxy acids. J Am Acad Dermatol. 1984;11(5, pt 1):867-879.
10. Bruner CR, Feldman SR, Ventrapragada M, et al. A systematic review of adverse effects associated with topical treatments for psoriasis. Dermatol Online J. 2003;9:2.
11. Gottlieb AB, Staiano-Coico L, Cohen SR, et al. Occlusive hydrocolloid dressings decrease keratinocyte population growth fraction and clinical scale and skin thickness in active psoriatic plaques. J Dermatol Sci. 1990;1:93-96.
12. David M, Lowe NJ. Psoriasis therapy: comparative studies with a hydrocolloid dressing, plastic film occlusion, and triamcinolone acetonide cream. J Am Acad Dermatol. 1989;21(3, pt 1):511-514.
13. Friedman SJ. Management of psoriasis vulgaris with a hydrocolloid occlusive dressing. Arch Dermatol. 1987;123:1046-1052.